Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Seminars in Cancer Biology|December 4, 2008
Chemokines and the microenvironment in neuroectodermal tumor-host interactionRajasekharan Somasundaram, Dorothee HerlynExpert Review of Anticancer Therapy|September 25, 2015
Nivolumab in combination with ipilimumab for the treatment of melanomaRajasekharan Somasundaram, Meenhard HerlynThe Journal of Investigative Dermatology|April 16, 2014
Indomethacin to the rescue of TRAIL-resistant melanomasRajasekharan Somasundaram, Meenhard HerlynThe Journal of Investigative Dermatology|February 13, 2013
Combination therapy of immunocytokines with ipilimumab: a cure for melanoma?Tao Wang, Rajasekharan Somasundaram, Meenhard HerlynAdvances in Pharmacology (San Diego, Calif.)|September 11, 2012
Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulationsRajasekharan Somasundaram, Jessie Villanueva, Meenhard HerlynJournal of Cancer Biology|October 25, 2022
Challenges in the humanized mouse model for cancer: A commentaryEric Ramirez-Salazar, Meenhard Herlyn, Rajasekharan SomasundaramMelanoma Management|September 8, 2018
The role of tumor microenvironment in melanoma therapy resistanceRajasekharan Somasundaram, Meenhard Herlyn, Stephan N WagnerNature Communications|June 7, 2020
Pre-clinical modeling of cutaneous melanomaVito W Rebecca, Rajasekharan Somasundaram, Meenhard HerlynJournal of Translational Medicine|November 12, 2005
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanomaRajasekharan Somasundaram, Laura Caputo, DuPont Guerry, et al.Cancer Treatment and Research|November 26, 2015
Heterogeneity in MelanomaBatool Shannan, Michela Perego, Rajasekharan Somasundaram, et al.Pageof 6